Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Portuguese research shows Helicobacter pylori cancer risk:

This article was originally published in Clinica

Executive Summary

Individuals infected with certain strains of the Helicobacter pylori bacterium and who have specific genetic polymorphisms are more likely to develop stomach cancer, say US researchers. The 443-patient study, conducted at the University of Porto, Portugal, found that people with a high-activity version of the interleukin-1 beta gene who were infected with H Pylori with a particular variant of the vacA vacuolating cytotoxin had a nearly 90-fold increase in risk of stomach cancer. The findings appear in the Journal of the National Cancer Institute (November 20).





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts